Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
Alejandra Maciel, Ali Cullors, Andrew A Lukowiak, Jorge Garces AltheaDx, San Diego, CA, USA Abstract: The burden of depression significantly impacts the patient, the health care system, and society, at large. Medication management guided by pharmacogenetics has been shown to increase therapeutic e...
Enregistré dans:
Auteurs principaux: | Maciel A, Cullors A, Lukowiak AA, Garces J |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4d941f45cf7e49d995b22e26b72b4f95 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
par: L. K. Khokhlov, et autres
Publié: (2019) -
Efecto de las variantes de VKORC1 y CYP2C9 sobre la dosis de anticoagulantes orales en individuos chilenos
par: Benavides,Felipe, et autres
Publié: (2015) -
Pharmacogenetics
Publié: (1991) -
PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
par: D. D. Morikov, et autres
Publié: (2017) -
Pharmacogenetics of hypoglycemic agents
par: Irina Vladimirovna Kononenko, et autres
Publié: (2015)